To examine the role of cytokines in mediating the lipogenic effects of endotoxin (LPS), we studied the effects of LPS and cytokines on hepatic fatty acid synthesis in LPS-sensitive C3H/OuJ mice and in LPS-resistant C3H/HeJ mice, whose macrophages are defective in the ability to produce tumor necrosis factor (TNF) and IL-1 in response to LPS. HeJ mice were 16-fold less sensitive than OuJ mice to the lipogenic effect of LPS. In OuJ mice, 10 Asg of LPS caused a maximal increase in hepatic lipogenesis (3.86±0.41-fold), whereas in HeJ mice the maximal increase was only 1.79±032-fold after 100 ,gg of LPS. This lipogenic response paralleled the decreased ability of LPS to increase hepatic and splenic levels of mRNAs for TNF and IL-1 and serum levels of TNF in HeJ mice. In contrast, the maximal effect ofTNF on lipogenesis was greater and the sensitivity to TNF was increased 2.4-fold in HeJ mice compared to OuJ mice. Administration of IFN-'y before LPS in HeJ mice had no effect on IL-1 mRNA, but partially restored the LPS-induced increase in hepatic and splenic mRNA for TNF and serum TNF levels, which may account for the partial restoration of sensitivity to the lipogenic effect of LPS after IFN-'y treatment. These results indicate that cytokines produced by mononuclear leukocytes mediate the lipogenic effects of LPS. (J. Clin. Invest. 1992.89:1603-1609
Introduction
In addition to destroying infectious agents and developing immunity to subsequent challenge by these agents, the host responds to infection with multiple changes in intermediary metabolism (1) . Prominent among these changes is hypertriglyceridemia due to the accumulation ofvery low density lipoprotein (VLDL), which is seen both in response to endotoxin (LPS) and during infection (2) (3) (4) (5) (6) (7) . Infection or LPS may increase serum triglycerides by at least two mechanisms: (a) a decrease in triglyceride clearance due to reductions in lipoprotein lipase activity (5); (b) an increase in VLDL production that may be due to increased de novo synthesis of fatty acids (6) or increased reesterification of fatty acids derived from the periphery (7).
The host response to infection is coordinated by a variety of cytokines including the tumor necrosis factors (TNF),' the interleukins (IL), and the interferons (IFN) (8) (9) (10) . It is likely that these cytokines also mediate the metabolic disturbances that occur during infection. In vivo, TNF causes hypertriglyceridemia by increasing hepatic VLDL production through a combination ofincreased fatty acid synthesis in the liver and reesterification of peripherally derived fatty acids, rather than by decreasing lipoprotein lipase and triglyceride clearance (11) (12) (13) (14) (15) (16) . IL-1, IL-6, and IFN-a have also been shown to increase hepatic fatty acid synthesis (17, 18) . TNF and IL-1 increase hepatic fatty acid synthesis at the same doses that induce fever, suggesting that the metabolic changes in the liver are closely linked to the response to infection (17) .
Although it appears logical that cytokines would also mediate the metabolic disturbances of infection, their role has not been directly tested in vivo. Therefore, we have studied the response to LPS in an LPS-resistant mouse strain (C3H/HeJ) and an LPS-sensitive mouse strain (C3H/OuJ). C3H/HeJ mice show decreased responses to LPS, including a decrease in the ability of LPS to induce production of cytokines such as TNF and IL-I by their macrophages (19) (20) (21) (22) (23) (24) (25) . However, treatment of cultured macrophages from C3H/HeJ mice with IFN-'y in vitro restores the ability of LPS to increase levels of TNF and IL-1 mRNA and TNF protein in response to LPS in vitro (26) (27) (28) . Recent data suggest that adherent monocytes or macrophages studied in vitro may show different regulation of both cytokine gene expression and cytokine protein production than is seen in vivo (10, 29) .
Therefore, we have studied intact C3H/HeJ mice and demonstrate that, in parallel to their decreased ability to produce cytokine mRNA and protein in response to LPS in vivo, C3H/ HeJ mice show a dramatically reduced ability to increase hepatic fatty acid synthesis after endotoxin challenge. However, treatment of C3H/HeJ mice in vivo with murine IFN-y partially restores both the ability of these mice to produce TNF in response to LPS in vivo and the ability of LPS to stimulate hepatic fatty acid synthesis.
Francisco, CA). Recombinant human IL-1B (1 12-269) with a specific activity of 5 X 107 U/mg was produced as described previously (30 Animals. Male mice, 4-5 wk old (C3H/OuJ and C3H/HeJ) were purchased from Jackson Laboratories Inc. (Bar Harbor, ME). C3H/ OuJ is a substrain that was separated from the C3H/HeJ strain before the origin of the defective LPS response in C3H/HeJ; C3H/OuJ is sensitive to LPS and has many of the characteristics of the original CeH/HeJ strain (data on file, Jackson Laboratories, Inc.). Animals were maintained on a normal 12-h light cycle and were fed Purina Mouse Chow (Ralston Purina Co., St. Louis, MO) and water ad libitum. On the morning ofthe study, after removal of food, animals were divided into groups of 5 and injected with the specified doses of LPS and/or cytokine or with the appropriate vehicle alone (controls). LPS was administered i.p. in 0.9% saline solution. Murine TNF-a, IL-lI#, and IFN-'y were administered i.m. in 0.1% human serum albumin, a diluent which has previously been shown to have no effect on hepatic lipogenesis (17) .
Measurement of lipogenesis. 3H20 (10 mCi) was injected i.p. 4 h after LPS or 1 h after TNF or IL-1 administration. 1 h later the animals were weighed and a blood specimen was obtained. The animals were euthanized and incorporation of 3H20 into fatty acids in the liver was determined as described previously (17) . The validity ofour methodology for measuring lipid synthesis has been demonstrated in earlier publications (33, 34) .
TNF assay. TNF activity in serum was measured using the TNFsensitive cell line, WEHI 164 clone 13, in a cytotoxicity assay which was developed using 344,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium blue (35) . Concentrations were calculated by comparison with a recombinant murine TNF-a standard. Northern blot analysis. Total RNA was isolated using the guanidine isothiocyanate phenol-chloroform extraction method (36) and batch absorbed to oligo (dT)-cellulose; polyadenylated mRNA was then batch eluted (37 contrast, in HeJ mice, 100 ,ug of LPS stimulated hepatic fatty acid synthesis by only 1.79±0.32-fold (P < 0.05 vs. saline control). The ability ofLPS to stimulate hepatic fatty acid synthesis in HeJ mice at 0.1-10 ,ug was significantly less than that seen with OuJ mice (P < 0.002).
Effect of LPS on cytokine mRNA. mRNA was prepared from mouse liver and spleen 2 h after LPS or saline administration. Northern blot analysis was performed using full-length cDNA probes for murine TNF and IL-IB (Fig. 2 ). TNF mRNA was not detected in the liver of saline-treated animals ( Fig. 2 LPS (Cg) Figure 3 . Effect of LPS on splenic cytokine mRNA in LPS-sensitive (C3H/OuJ) and LPS-resistant (C3H/HeJ) mice. The protocol used is identical to that in Fig. 2 except that spleens were used. Blots were exposed to film for 1 h for TNF and 2 h for IL-l.
induced by 1 gg ofLPS in OuJ mice. A similar pattern was seen for LPS induction of the hepatic mRNA for IL-1 (Fig. 2 ).
In the spleen the same differential effect ofLPS was seen on cytokine mRNAs (Fig. 3 ). Significant induction of TNF and IL-I mRNAs could be seen at doses as low as 0.01 ug of LPS in OuJ mice. Maximal response was seen between 1 and 10 ,g of LPS. In contrast, significant induction of the mRNA for TNF and IL-1 was not seen in the spleen ofHeJ mice until LPS doses of 10 Aig were used; 100 ,ug of LPS was needed in HeJ mice to reach mRNA levels for TNF and IL-1 that are comparable to those seen at much lower doses in OuJ mice (Fig. 3) .
Effect ofLPS on serum TNF levels. TNF was not detectable in the serum of mice 120 min after the administration of saline (Fig. 4) . Administration of LPS caused a striking increase in serum TNF levels with a peak value of 10.1±2.5 ng/ml at 1 jtg of LPS in OuJ mice (Fig. 4) . In contrast, LPS is markedly less effective at inducing TNF in HeJ mice with a peak value of 0.18±0.03 ng/ml serum observed at 100 ,ug of LPS (Fig. 4 moved, mRNA was extracted and Northern blots were performed as described under Methods. Although the technique is identical to that in Fig. 2 , the blots were exposed for 3 d for TNF and 24 h for IL- 1. vitro has been shown to restore their responsiveness to LPS (26-28), we determined whether treatment of intact HeJ mice with IFN-y could restore the ability ofLPS to induce cytokines and increase hepatic fatty acid synthesis in vivo. HeJ mice were treated with 50 ,gg of IFN-y or saline i.m., followed by either saline or 5 ,ug of LPS i.p. 2 h later, livers and spleens were removed and poly A-rich RNA was prepared. Consistent with our earlier observations, 5 ,gg ofLPS alone could induce a small amount of mRNA for TNF (Fig. 7) . IFN-'y by itself had no effect on mRNA for TNF in liver. However, the combination of IFN-'y followed by LPS induced a ninefold increase in the mRNA for TNF in liver compared to endotoxin alone (also see Table I where data are expressed relative to the mRNA for actin).
As seen previously, there was negligible mRNA for IL-1 in the liver of saline-treated mice; however, 5 ug of LPS alone induced detectable amounts of mRNA for IL-I in HeJ mice (Fig. 7 , Table I ). Administration of IFN-'y had minimal effect on IL-l mRNA in liver. In contrast to the results with TNF, the combination of IFN-y plus LPS induced little further increase in hepatic IL-I mRNA compared to LPS alone. Similar data were obtained when analyzing the mRNA for TNF and IL-I in spleen (Fig. 8 , Table I ). LPS alone induced a small amount of mRNA for TNF; the combination of IFN-y plus LPS resulted in a striking increase in the amount of TNF mRNA in spleen. LPS alone induced a significant increase in the mRNA for IL-1 in spleen. However, the combination of IFN-y and LPS caused no further increase in splenic IL-I and mRNA compared to LPS alone.
We then tested the effect of IFN-'y on serum TNF levels. Consistent with the data in Fig. 4 , treatment ofHeJ mice with 5 ,gg of LPS alone led to low but detectable levels of TNF in the serum (Table I) . IFN-'y by itself was not able to induce detectable levels of TNF. However, the combination of 50 ,gg of IFN gamma and 5 gg of LPS produced a 17-fold increase in serum TNF levels compared to LPS alone (Table I) . Thus, the effect of IFN-'y on the ability of LPS to induce TNF mRNA was paralleled by the effect of IFN-y at enhancing the LPS-induced increases in serum TNF levels (Table I) . Serum levels of IL-1 were not measured, owing to the difficulty in reliably interpreting circulating IL-l levels given the presence of inhibitors in serum.
In parallel to its effects on TNF mRNA and circulating protein levels, IFN-y was able to partially restore the ability of LPS to stimulate hepatic fatty acid synthesis in C3H/HeJ mice. In two separate experiments, HeJ mice were treated with two different doses of LPS that had no significant effect on hepatic fatty acid synthesis (Fig. 9) . IFN-,y alone at 50 ,gg was also not able to stimulate hepatic lipogenesis significantly (Fig. 9) . However, treatment of HeJ mice with 50 tig of IFN-y just before treatment with LPS restored the ability of LPS to stimulate hepatic fatty acid synthesis at these doses (Fig. 9) . The combination of 50 ,ug of IFN-y and 5 ,gg ofLPS gave a twofold stimulation of hepatic fatty acid synthesis over control levels.
Discussion
The host response to infectious and inflammatory stimuli results in changes in lipid metabolism such as increased plasma triglycerides, hepatic fatty acid synthesis, and VLDL production (1) (2) (3) (4) (5) (6) (7) . The ability of cytokines to induce these same changes in lipid metabolism (11) (12) (13) (14) (15) (16) (17) (18) suggested that cytokines mediate the metabolic response to infection. To examine this hypothesis, we studied the effects of LPS and cytokines on C3H/HeJ mice, a strain that is genetically resistant to the ef- (26) (27) (28) ; the secretion ofIL-1 was not specifically studied in those experiments (27) . However, recent data raise questions as to whether cytokine induction in vitro is different from that seen in vivo, perhaps owing to the process of adherence of cells to plastic or to low level contamination with LPS (10, 29) . In this article we show that genetic resistance to the ability of LPS to induce cytokines is paralleled by resistance to one of the metabolic effects of LPS, the ability to stimulate hepatic lipogenesis. We have shown that C3H/HeJ mice are resistant to the ability of LPS to induce the mRNA for TNF and IL-1 in liver and spleen in vivo when compared to the LPS-sensitive strain C3H/OuJ. Furthermore, this study demonstrates that LPS was less effective at increasing circulating TNF levels in C3H/HeJ mice. Previous data have suggested that the major source ofTNF in the circulation is the splanchnic bed (38) , and it is therefore likely that both liver and spleen contribute to circulating TNF levels. To our knowledge the resistance of C3H/HeJ mice to LPS induction of TNF and IL-1 has not previously been demonstrated in vivo. With regards to other effects ofLPS in vivo, several laboratories have shown that LPS is less capable ofinducing circulating granulocyte/macrophage colony-stimulating factor and interferon activity in C3H/HeJ mice (39) (40) (41) .
Consistent with the proposal of Beutler et al. (24) based on in vitro studies, we find evidence in vivo for a defect in the post-transcriptional regulation of TNF protein in addition to the defect in induction of TNF mRNA. The maximal dose of LPS tested in C3H/HeJ mice (100 ,ug) induces similar levels of TNF mRNA in liver and spleen compared to much lower doses in C3H/OuJ mice. Yet the absolute levels of TNF protein found in the circulation of C3H/HeJ mice under these conditions of LPS stimulation remain strikingly lower than the level ofTNF seen in the circulation ofC3H/OuJ mice having similar mRNA levels. It remains to be determined whether these posttranscriptional changes occur at the level oftranslation ofTNF mRNA, within the secretory pathway for TNF protein or at the level ofdegradation ofprotein. Thus, although in some in vitro macrophage/monocyte systems cytokine mRNA may be increased without production of cytokine protein as a result of the conditions ofincubation in vitro (29) , the C3H/HeJ mouse shows defects in both expression of TNF mRNA and the appearance of TNF protein in vivo, similar to what is seen with their macrophages in vitro.
In parallel to the resistance of C3H/HeJ mice to cytokine induction by LPS, these mice were resistant to the ability of LPS to stimulate hepatic fatty acid synthesis, showing both a decrease in the sensitivity to LPS and a decrease in the maximal responsiveness to LPS. This finding indicates that products of LPS-activated mononuclear leukocytes mediate the effect of LPS on hepatic fatty acid synthesis.
We also studied the relative ability of cytokines to directly stimulate hepatic fatty acid synthesis in these two mice strains. In contrast to the resistance to LPS, C3H/HeJ mice were significantly more responsive to the ability of TNF to stimulate hepatic fatty acid synthesis than C3H/OuJ mice, both in terms of maximal response and sensitivity. It is likely that C3H/HeJ mice are not exposed to significant amounts of circulating TNF during life, owing to their defect in the ability to induce TNF. Therefore these mice may have an upregulated response to TNF.
IFN-y treatment of macrophages from C3H/HeJ mice in vitro partially restores their ability to respond to LPS by increasing TNF mRNA and protein levels in vitro (26) (27) (28) . We [16] [17] [18] and were seen here within 4 h after the response to LPS. The doses ofTNF and IL-l required to stimulate hepatic fatty acid synthesis are similar to those that induce fever (17) . Here we show that the dose of LPS required to stimulate hepatic fatty acid synthesis in the sensitive mouse strain, C3H/OuJ, is several orders of magnitude less than that which induces death in LPS sensitive mice (19) (20) (21) . Thus, it is not surprising that treatment with IFN-,y, which begins to restore the ability of LPS-resistant C3H/HeJ mice to respond to LPS with TNF production also restores the ability of these mice to respond to LPS with an increase in hepatic fatty acid synthesis; C3H/HeJ mice are also more sensitive to TNF, requiring less TNF to increase hepatic lipogenesis compared to C3H/OuJ mice.
The resistance of C3H/HeJ mice to the effects of LPS includes resistance to LPS-induced lethality (19) (20) (21) , which is also likely to be due to the defect in macrophage TNF and IL-I secretion, inasmuch as both TNF and IL-1 have been implicated as mediators of LPS-induced shock (45-47). However, this defect in LPS responsiveness dramatically reduces the ability of C3H/HeJ mice to successfully survive infection (48-5 1), because such cytokines are critical for host defense. Pretreatment of C3H/HeJ mice with TNF and/or IL-1 restores their ability to survive gram negative infection (52, 53) . Antibody blockade of TNF also induces susceptibility to infection (54, 55) . Thus, the induction of cytokines such as TNF and IL-l plays a significant role in host defense. In addition to modulating cells ofthe immune system, LPS, TNF, and IL-I induce the acute-phase response, a change in the program of liver protein synthesis and secretion that also plays a role in host defense (56, 57) . It is likely that the ability of these cytokines to increase hepatic fatty acid synthesis and VLDL secretion (1 1-18) is part of the acute-phase response. Recent evidence indicates that such changes in lipid metabolism may contribute to host defense. VLDL can bind LPS and prevent LPS lethality, a phenomenon shared by other lipoproteins (58, 59). In addition, VLDL in the circulation of normal humans contains sequestered LPS that has most likely been scavenged during the course of physiological low grade endotoxinemia (59) . Lipoproteins also inactivate viruses and parasites (60) (61) (62) (63) (64) (65) . It is therefore possible that the role of the tight linkage between the immune response and lipid metabolism is to increase circulating lipoprotein levels during infection or to at least maintain lipoproteins at the normal level ofcirculation in the face of LPS or infection-induced anorexia.
